The experience of rucaparib in women with ovarian cancer
- Conditions
- Ovarian cancerCancerMalignant neoplasm of ovary
- Registration Number
- ISRCTN10125751
- Lead Sponsor
- HS Greater Glasgow and Clyde
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped
- Sex
- Female
- Target Recruitment
- 34
1. Women where a decision has been made to start rucaparib as part of standard care for maintenance treatment recurrent ovarian cancer following to platinum based chemotherapy and they have not yet started treatment
2. Written informed consent
3. Ability and willingness to complete questionnaires in English
4. Meet institutional criteria for treatment in standard practice
1. Prior treatment with a poly ADP ribose polymerase (PARP) inhibitor
2. Current treatment with another maintenance therapy for ovarian cancer
3. Participation in another trial of an investigational medicinal product (IMP) (participation in another observational or sample collection trial may be possible if both Sponsors agree and the burden on the patient is acceptable)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method